Wayland Group Corp. (MRRCF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Wayland Group Corp. (MRRCF) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 42/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Wayland Group Corp. (MRRCF) Gesundheitswesen & Pipeline-Uebersicht
Wayland Group Corp. is a Canadian cannabis company producing and selling medical and non-medical cannabis products internationally. Operating in the specialty and generic drug manufacturing sector, Wayland offers diverse cannabis strains under brands like Kiwi and Northern Harvest, targeting both medical patients and recreational consumers.
Investmentthese
Investing in Wayland Group Corp. (MRRCF) presents a high-risk, high-reward scenario. The company's negative profit margin of -2079.4% and gross margin of -154.9% indicate significant financial challenges. The company's success hinges on achieving substantial revenue growth and improved operational efficiency. Potential catalysts include expansion into new international markets and the introduction of innovative cannabis products. However, investors should be aware of the risks associated with the OTC market and the company's current financial performance. The company's beta of -44.34 suggests an inverse correlation with the market, which may offer some diversification benefits but also reflects the company's unique risk profile.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $0.00B indicates a micro-cap company with limited resources and higher volatility.
- P/E Ratio of -0.00 suggests the company is not currently profitable.
- Profit Margin of -2079.4% highlights significant losses and operational inefficiencies.
- Gross Margin of -154.9% indicates the company is selling products below cost.
- Beta of -44.34 suggests an inverse correlation with the market, indicating unique risk profile.
Wettbewerber & Vergleichsunternehmen
Staerken
- Established brands in the Canadian cannabis market.
- Diverse product portfolio with CBD, balanced, and THC strains.
- International expansion potential.
- Subsidiary of Maricann Group Inc.
Schwaechen
- Negative profit margin and gross margin.
- Limited market capitalization.
- High beta value indicating high volatility.
- OTC market trading with associated risks.
Katalysatoren
- Ongoing: Expansion into new international markets as cannabis regulations evolve globally.
- Ongoing: Development and introduction of innovative cannabis products to cater to specific consumer segments.
- Ongoing: Strategic partnerships and collaborations to access new markets, technologies, and distribution channels.
- Ongoing: Focus on the medical cannabis market to cater to patients with specific medical conditions.
- Ongoing: Efforts to enhance operational efficiency and reduce costs to improve profitability.
Risiken
- Ongoing: Intense competition in the cannabis industry leading to pricing pressures and market share erosion.
- Ongoing: Changing regulatory landscape impacting the company's operations and compliance costs.
- Potential: Fluctuations in cannabis prices affecting revenue and profitability.
- Ongoing: Limited access to capital hindering growth and expansion plans.
- Potential: Negative profit margin and gross margin indicating financial instability.
Wachstumschancen
- Expansion into international markets represents a significant growth opportunity for Wayland Group Corp. As cannabis regulations evolve globally, the company can leverage its expertise and product portfolio to enter new markets and capture market share. The global cannabis market is projected to reach billions of dollars in the coming years, offering substantial growth potential for companies that can successfully navigate regulatory hurdles and establish a strong presence.
- Development and introduction of innovative cannabis products can drive revenue growth and enhance Wayland Group Corp.'s competitive position. By focusing on research and development, the company can create unique and differentiated products that appeal to specific consumer segments. This includes exploring new delivery methods, formulations, and applications of cannabis. The market for innovative cannabis products is growing rapidly, driven by increasing consumer demand for novel and effective solutions.
- Strategic partnerships and collaborations can accelerate Wayland Group Corp.'s growth and expand its reach. By partnering with other companies in the cannabis industry, the company can access new markets, technologies, and distribution channels. This includes collaborations with research institutions, healthcare providers, and retail outlets. Strategic partnerships can also help the company to navigate regulatory complexities and access funding.
- Focus on medical cannabis market represents a significant growth opportunity for Wayland Group Corp. As the medical cannabis market continues to expand, the company can leverage its expertise and product portfolio to cater to patients with specific medical conditions. This includes developing cannabis-based therapies and providing educational resources to healthcare professionals. The medical cannabis market is driven by increasing awareness of the therapeutic benefits of cannabis and the growing acceptance of cannabis as a treatment option.
- Enhancing operational efficiency and reducing costs can improve Wayland Group Corp.'s profitability and financial performance. By streamlining its operations, optimizing its supply chain, and implementing cost-saving measures, the company can improve its gross margin and profit margin. This includes investing in automation, improving inventory management, and negotiating favorable terms with suppliers. Improved operational efficiency can also enhance the company's competitiveness and ability to respond to changing market conditions.
Chancen
- Expansion into new international markets.
- Development of innovative cannabis products.
- Strategic partnerships and collaborations.
- Growth in the medical cannabis market.
Risiken
- Intense competition in the cannabis industry.
- Changing regulatory landscape.
- Fluctuations in cannabis prices.
- Limited access to capital.
Wettbewerbsvorteile
- Brand recognition through established brands like Kiwi and Northern Harvest.
- Proprietary cannabis strains and formulations.
- Established distribution network in Canada.
- International expansion potential.
Ueber MRRCF
Wayland Group Corp., established in 2013 and based in Oakville, Canada, is a producer and seller of medical and non-medical cannabis. The company caters to cannabis patients and consumers both in Canada and on the international market. Wayland Group operates as a subsidiary of Maricann Group Inc. Wayland offers a diverse portfolio of cannabis strains, including CBD, balanced, and THC varieties, marketed under various brand names such as Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann. These brands allow the company to target different consumer segments and preferences within the cannabis market. The company's focus is on cultivating and distributing cannabis products to meet the demands of both medical and recreational users. Wayland Group's operations are primarily based in Canada, but the company also aims to expand its reach internationally. The company's strategy involves developing a range of products and brands to capture a significant share of the cannabis market. Wayland Group's business model is centered around the production, distribution, and sale of cannabis products, with a focus on quality and innovation.
Was das Unternehmen tut
- Produces medical cannabis for patients.
- Produces non-medical cannabis for consumers.
- Sells cannabis products in Canada.
- Sells cannabis products internationally.
- Offers CBD cannabis strains.
- Offers balanced cannabis strains.
- Offers THC cannabis strains.
Geschaeftsmodell
- Cultivates and processes cannabis plants.
- Packages and brands cannabis products.
- Distributes cannabis products through various channels.
- Sells cannabis products directly to consumers and retailers.
Branchenkontext
Wayland Group Corp. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing competition as more companies enter the space and as legalization expands. Wayland Group competes with other cannabis producers and distributors, both in Canada and internationally. The company's ability to differentiate its products and establish a strong brand presence will be crucial for success. The industry is also subject to changing consumer preferences and regulatory requirements, which can impact the company's operations and financial performance.
Wichtige Kunden
- Medical cannabis patients in Canada.
- Recreational cannabis consumers in Canada.
- International cannabis consumers.
- Retailers and distributors of cannabis products.
Finanzdaten
Chart & Info
Wayland Group Corp. (MRRCF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Stocks That Hit 52-Week Lows On Thursday
· 10. Okt. 2019
-
Stocks That Hit 52-Week Lows Of Monday
· 7. Okt. 2019
-
Stocks That Hit 52-Week Lows On Friday
· 4. Okt. 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· 2. Okt. 2019
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer MRRCF.
Kursziele
Wall-Street-Kurszielanalyse fuer MRRCF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von MRRCF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: David Miller
Managing
David Miller currently manages 68 employees at Wayland Group Corp. Information regarding his detailed career history, education, and previous roles is not available in the provided data. Therefore, a comprehensive background profile cannot be constructed at this time. Further research would be required to ascertain his specific expertise and experience within the cannabis industry or related fields.
Erfolgsbilanz: Due to limited information, David Miller's specific achievements, strategic decisions, and company milestones under his leadership at Wayland Group Corp. cannot be accurately assessed. Additional data is needed to evaluate his impact on the company's performance and strategic direction. His tenure length is also unknown.
MRRCF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Wayland Group Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to companies on more regulated exchanges.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure and transparency.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater price volatility.
- Limited regulatory oversight.
- Verify the company's legal registration and business licenses.
- Review available financial statements and assess their accuracy.
- Research the background and experience of the company's management team.
- Evaluate the company's business model and competitive landscape.
- Assess the company's compliance with relevant regulations.
- Understand the risks associated with the OTC market and the company's specific circumstances.
- Consult with a qualified financial advisor before investing.
- Company has been in operation since 2013.
- Company has a physical headquarters in Oakville, Canada.
- Company has a range of cannabis products under multiple brand names.
- Company is a subsidiary of Maricann Group Inc.
MRRCF Healthcare Aktien-FAQ
What are the key factors to evaluate for MRRCF?
Wayland Group Corp. (MRRCF) currently holds an AI score of 42/100, indicating low score. Key strength: Established brands in the Canadian cannabis market.. Primary risk to monitor: Ongoing: Intense competition in the cannabis industry leading to pricing pressures and market share erosion.. This is not financial advice.
How frequently does MRRCF data refresh on this page?
MRRCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MRRCF's recent stock price performance?
Recent price movement in Wayland Group Corp. (MRRCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands in the Canadian cannabis market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider MRRCF overvalued or undervalued right now?
Determining whether Wayland Group Corp. (MRRCF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying MRRCF?
Before investing in Wayland Group Corp. (MRRCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MRRCF to a portfolio?
Potential reasons to consider Wayland Group Corp. (MRRCF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Established brands in the Canadian cannabis market.. Additionally: Diverse product portfolio with CBD, balanced, and THC strains.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of MRRCF?
Yes, most major brokerages offer fractional shares of Wayland Group Corp. (MRRCF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MRRCF's earnings and financial reports?
Wayland Group Corp. (MRRCF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for MRRCF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited financial data available for in-depth analysis.
- OTC market carries inherent risks.
- Analyst coverage is non-existent.